TITLE

ARBs and cancer risk

PUB. DATE
July 2011
SOURCE
Internal Medicine Alert;7/15/2011 Pharmacology Watch, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that the findings of the meta-analysis conducted by the U.S. Food and Drug Administration (FDA) concerning the possible link between angiotensin receptor blockers (ARBs) and cancer reveal that ARBs are not associated with cancer.
ACCESSION #
65206160

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics